Osteoporosis is found in 20–50% of NF1 patients, and it is associated with reduced serum 25-hydroxyvitamin D and increased serum concentrations of parathyroid hormone (PTH) and biochemical markers indicating bone turnover, such as osteocalcin or alkaline phosphatase (ALP) [17]. Here, PTH is linked to neurofibromatosis type 1.